ARTICLE | Clinical News
Valganciclovir regulatory update
March 5, 2001 8:00 AM UTC
The FDA's Anti-Viral Drugs Advisory Committee voted 12-1 to recommend marketing approval of ROCZ's valganciclovir, a prodrug of the company's Cytovene ganciclovir, to treat cytomegalovirus (CMV) reti...